Peptides sold for research purposes occupy a genuine regulatory grey area in South Africa. They are not explicitly approved as medicines, nor are they scheduled as controlled substances outright — but they are also not licensed for human therapeutic use through any formal channel. This is why every reputable supplier labels them "for research and laboratory use only" and avoids making therapeutic claims, since making a medical claim about a substance is what triggers full Medicines Act regulation.
The South African Health Products Regulatory Authority (SAHPRA) has published public guidance on peptide products and has increased its monitoring of peptide imports, with enforcement action taken against illicit distribution — particularly around weight-loss injectables sold without any regulatory oversight. Buying unscheduled research peptides in small quantities for personal research is generally permitted, while scheduled compounds require a prescription and a SAHPRA import permit.
In practice, this means: buy from a supplier that provides a Certificate of Analysis, keep purchases within personal research quantities, and understand that no research peptide is approved for human consumption by any regulator — informed, independent judgment is entirely on the buyer.
Study-backed guides, dosing protocols, and the full research peptide collection — all in one place.